The Viscosupplementation Guide: Our Orthopedic Selection at RM365 Netherlands

Osteoarthritis affects millions of patients across Europe and remains the leading cause of consultation for joint pain. This degenerative condition is not limited to simple cartilage wear; it impacts the entire joint ecosystem. At RM365 Netherlands, we support healthcare professionals across Europe by providing the most advanced viscosupplementation devices: Durolane, Cingal, Monovisc, Orthovisc, and Synvisc-One.

Why Has Viscosupplementation Become Essential?

Osteoarthritis is not merely a matter of cartilage degradation; it also leads to alterations in synovial fluid, which loses its lubricating and shock-absorbing properties. The injection of exogenous hyaluronic acid helps restore joint homeostasis, reduce pain, and stimulate the natural production of hyaluronic acid.

Targeted Expertise: European Orthopedic Standards

The European medical landscape demands absolute rigor. At RM365 Netherlands, we do more than distribute medical devices; we carefully select molecules whose safety and clinical efficacy are validated by the highest health authorities within the European Union.

Durolane: Stabilization Through NASHA Technology

Durolane has become a standard in European protocols thanks to its stabilized, non-animal-derived structure. Its exceptional resistance to enzymatic degradation allows for a single injection with prolonged intra-articular residence time, thereby minimizing iatrogenic risks associated with repeated injections.

Cingal: A Hybrid Immediate Approach

Cingal addresses a complex clinical need: rapid relief of inflammatory flare-ups while ensuring mechanical protection. By combining a corticosteroid with hyaluronic acid, it delivers a dual therapeutic response that is highly valued in sports medicine centers across Europe.

Synvisc-One: Excellence of Hylane Structure

A benchmark product from Sanofi, Synvisc-One (Hylane G-F 20) replicates the rheological properties of healthy synovial fluid. Its specific cross-linked structure provides superior cushioning and lubrication properties, essential for managing knee osteoarthritis in active patients.

Monovisc & Orthovisc: High Molecular Weight Purity

Developed by Anika Therapeutics, these solutions are distinguished by their high molecular weight and excellent biocompatibility. They form the foundation of treatment for European specialists who prioritize ultra-pure sodium hyaluronate-based products.

RM365: Your Strategic Partner for European Supply

RM365’s strength lies in its ability to combine scientific expertise with operational excellence in medical distribution across Europe.

• European compliance and authenticity: All our devices are authentic and strictly compliant with current European regulations.
• Responsiveness and fast delivery: Thanks to our logistics infrastructure at the heart of Europe, we ensure agile and express distribution across all EU countries (France, Germany, Ireland, Italy, etc.). This proximity guarantees continuity of care and optimized stock management for your facilities.

Innovation Serving Mobility

Choosing a viscosupplement is a therapeutic decision that must be tailored to the stage of the disease and the patient’s profile. As a trusted European partner, RM365 Netherlands provides you with the most advanced tools to stabilize the joint environment and restore function.

Frequently Asked Questions